RAO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 500
EU - Europa 393
AS - Asia 82
Continente sconosciuto - Info sul continente non disponibili 1
Totale 976
Nazione #
US - Stati Uniti d'America 496
IE - Irlanda 118
SE - Svezia 80
UA - Ucraina 73
CN - Cina 72
DE - Germania 41
GB - Regno Unito 32
FI - Finlandia 19
CZ - Repubblica Ceca 14
RU - Federazione Russa 5
IN - India 4
BE - Belgio 3
CA - Canada 3
SG - Singapore 3
FR - Francia 2
IR - Iran 2
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 976
Città #
Jacksonville 121
Dublin 118
Chandler 97
Nyköping 68
Ashburn 34
Beijing 30
Dearborn 28
Cambridge 18
Medford 18
Princeton 18
Des Moines 15
Boardman 14
Brno 14
Ann Arbor 12
Lancaster 10
Los Angeles 7
Nanjing 6
Hebei 5
Jinan 4
San Mateo 4
Shenyang 4
Zhengzhou 4
Brussels 3
Edinburgh 3
Frankfurt am Main 3
Haikou 3
Munich 3
Ottawa 3
Taizhou 3
Wilmington 3
Ardabil 2
Bangalore 2
Leawood 2
Singapore 2
Taiyuan 2
Tianjin 2
Woodbridge 2
Augusta 1
Bucharest 1
Changsha 1
Copenhagen 1
Cormeilles-en-Parisis 1
Hangzhou 1
Hanover 1
Helsinki 1
Kemerovo 1
Kyiv 1
Lisbon 1
Manchester 1
Mumbai 1
Nanchang 1
New York 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Panama City 1
Paris 1
Pune 1
Riva 1
Saint Louis 1
Saint Petersburg 1
Stockholm 1
Vienna 1
Washington 1
Xiangfen 1
Zagreb 1
Ürümqi 1
Totale 717
Nome #
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 73
Anti-HIV agents: design and discovery of new potent RT inhibitors 68
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 65
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 62
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 61
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 59
Efficient 3D Database screening for novel HIV-1 IN inhibitors 59
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 57
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 57
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 54
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 54
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 53
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 50
Synthesis and structural features of new cyclofunctionalized benzimidazoles 50
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 46
Synthesis of new potential HIV-1 integrase inhibitors 44
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 42
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 39
Totale 993
Categoria #
all - tutte 4.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.029


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 17 0 17 0 27 22 21 2 28 18 0
2020/2021111 18 0 24 1 1 17 0 17 0 18 14 1
2021/2022120 5 35 2 3 8 0 11 3 0 1 15 37
2022/2023391 23 32 27 23 32 42 5 35 149 2 20 1
2023/202479 5 13 2 22 5 13 1 0 0 2 1 15
2024/202510 5 5 0 0 0 0 0 0 0 0 0 0
Totale 993